| Upcoming events on ALBANY MOLECULAR RESEARCH, |
|
| 08/12/13 | | Q2 2013 Earnings Release (Projected) |
| 11/05/13 | | Q3 2013 Earnings Release (Projected) |
| 02/10/14 | | Q4 2013 Earnings Release (Projected) |
| 05/07/14 | | Q1 2014 Earnings Release (Projected) |
|
| Past events on ALBANY MOLECULAR RESEARCH, |
|
| 05/22/13 | 09:00am | | UBS Global Healthcare Conference |
| 05/07/13 | 10:00am | | Q1 2013 Earnings Call |
| 05/07/13 | | Q1 2013 Earnings Release |
| 04/30/13 | 12:50pm | | Needham Health Care Conference |
|
|
|
| Annual results | 2010 | 2011 | 2012 |
Sales
Million $ |
Released
Forecast
Spread | 198
197
0,39% | 208
210
-1,3% | 227
216
5,0% |
Operating income (EBITDA)
Million $ |
Released
Forecast
Spread | 8,93
8,17
9,3% | 5,59
4,47
25% | 32,4
29,1
11% |
Operating profit (EBIT)
Million $ |
Released
Forecast
Spread | -8,17
-9,22
11% | -12,4
-12,1
-2,3% | 15,0
11,6
29% |
Pre-Tax Profit (EBT)
$ |
Released
Forecast
Spread |
|
|
|
Net income
Million $ |
Released
Forecast
Spread | -62,9
-18,2
-246% |
|
|
EPS
$ |
Released
Forecast
Spread | -2,05
-0,60
-242% | -1,08
-0,34
-218% |
| | Announcement Date | 02/07/2011 | 02/07/2012 | 02/12/2013 |
|
| Quarterly / Semiannualy publications |
|
| Quarterly results | Q2
2012 | Q3
2012 | Q4
2012 |
Sales
Million $ |
Released
Forecast
Spread | 50,0
52,0
-3,8% | 55,8
50,8
9,8% | 67,2
56,5
19% |
Operating income (EBITDA)
Million $ |
Released
Forecast
Spread | 7,30
4,19
74% | 5,68
3,37
69% | 12,2
8,76
39% |
Operating profit (EBIT)
Million $ |
Released
Forecast
Spread | 2,93
0,71
314% | 1,52
-0,94
262% | 7,93
4,47
77% |
Pre-Tax Profit (EBT)
Million $ |
Released
Forecast
Spread | 1,52
|
|
|
Net income
Million $ |
Released
Forecast
Spread | 0,26
-0,55
147% |
|
|
EPS
$ |
Released
Forecast
Spread | 0,01
-0,02
150% |
|
| | Announcement Date | 08/01/2012 | 11/06/2012 | 02/12/2013 |
|
© 2013 Thomson Reuters
© 2013 Factset
|
|
| Net sales - Rate of surprise |
|
|
| Operating profit - Rate of surprise |
|
|
|
Previous year
